HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation.

Abstract
It is well known that atrial fibrillation (AF) is one of the most important diseases that predispose patients to thrombosis. We have attempted to identify patients with AF in the hypercoagulable state by measuring molecular markers such as thrombin-antithrombin III complex (TAT) and prothrombin fragment 1 + 2 (PTF) and determining the effect of antithrombotic therapy on these markers; 83 patients with AF were studied. Increased levels of plasma TAT and PTF were more frequently observed in patients with AF and associated mitral stenosis than in patients with AF alone. In cases of AF without mitral stenosis, plasma levels of TAT and PTF were significantly lower in those patients receiving antithrombotic agents (aspirin or warfarin) than in those receiving no antithrombotic agents. Furthermore, plasma levels of PTF were significantly lower in patients given warfarin than in those receiving aspirin. These results suggest that (1) patients with AF and mitral stenosis who are not given warfarin are in an extremely hypercoagulable state and (2) some patients with AF without mitral stenosis who are not given antithrombotic agents are also moderately hypercoagulable. In vivo activation of blood coagulation was more effectively controlled in patients receiving warfarin than in those taking aspirin.
AuthorsH Asakura, S Hifumi, H Jokaji, M Saito, I Kumabashiri, C Uotani, E Morishita, M Yamazaki, K Shibata, K Mizuhashi
JournalBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis (Blood Coagul Fibrinolysis) Vol. 3 Issue 4 Pg. 469-73 (Aug 1992) ISSN: 0957-5235 [Print] England
PMID1420823 (Publication Type: Journal Article)
Chemical References
  • Peptide Fragments
  • antithrombin III-protease complex
  • prothrombin fragment 1.2
  • Warfarin
  • Antithrombin III
  • Prothrombin
  • Peptide Hydrolases
  • Aspirin
Topics
  • Aged
  • Antithrombin III (metabolism)
  • Aspirin (therapeutic use)
  • Atrial Fibrillation (blood, complications)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peptide Fragments (metabolism)
  • Peptide Hydrolases (metabolism)
  • Prothrombin (metabolism)
  • Reference Values
  • Thrombosis (blood, etiology, prevention & control)
  • Warfarin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: